ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 659611 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 659611; 2) Community: the network communities that were significantly associated with the response to NSC 659611; 3) Molecule: the relationships between components within communities and NSC 659611; 4) MDR: the compounds that were significantly associated with the NSC 659611.

NSC Compound Enrichment Correlation
NSC 673420 Null 0.048939380959983 -0.018606976
NSC 677672 Null 0.048939380959983 0.18047784
NSC 677776 Null 0.048939380959983 -0.19677527
NSC 679001 2-Butenedioic acid, 2-[3-[(ethoxycarbonyl)methyl]-2,4-dioxopyrimidin-1-yl-, diethyl ester, (E)- 0.048939380959983 0.35830234
NSC 682764 Pyrido[3,2-d][1]benzazepin-6-one, 4-(4-chlorophenyl)-2-phenyl- 0.048939380959983 -0.035182918
NSC 683608 Null 0.048939380959983 0.19191993
NSC 683864 Temsirolimus 0.048939380959983 0.019216971
NSC 689539 Null 0.048939380959983 0.22143559
NSC 690118 Null 0.048939380959983 0.10853904
NSC 696257 2,3-Dihydro-1,2-syn-2-[S-(L)-cysteinylsulfoxide-]-brefeldin A 0.048939380959983 0.20045594
Total:115  Current:105    [First] [Prev] [Next] [Last]